Retatrutide (6mg/10mg)
-
Regular Price
-
$109.95
-
Sale Price
-
$109.95
-
Regular Price
-
Sold Out
-
Unit Price
- per
- Regular Price
- $109.95
- Sale Price
- $109.95
- Regular Price
- Unit Price
- per
Retatrutide
Research metabolism, cognitive clarity, and sustained energy with Retatrutide. Expertly formulated and backed by rigorous lab testing, it’s designed to support your research on the body’s natural vitality and overall wellness.
Specification:
| Unit Size | 6 or 10 mg/vial |
| Unit Quantity | 1 vial |
| Purity (HPLC) | 99.7% |
| Sequence | Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 (Sodium salt) |
| Molecular Formula |
C221H342N46O68 |
| Molecular Weight |
4731.33 |
| CAS |
2381089-83-2 |
| Appearance | lyophilized White Powder |
| Source | Chemical Synthesis |
| Storage | Iyophilized Retatrutide is to be stored at -20°C and reconstituted Retatrutide can be stored at 4°C. |
| Terms | The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering. |
Retatrutide is a novel investigational peptide therapy that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors. This unique mechanism sets it apart from earlier GLP-1–only treatments by targeting multiple pathways involved in energy balance, glucose regulation, and fat metabolism.
Originally developed for the treatment of obesity and type 2 diabetes, Retatrutide has shown strong potential in clinical studies for promoting weight loss, improving insulin sensitivity, and enhancing cardiovascular health. By combining GLP-1 and GIP agonism (which support satiety, insulin secretion, and improved glycemic control) with glucagon receptor activation (which increases energy expenditure and fat burning), Retatrutide offers a comprehensive approach to metabolic disease management.
Clinical trials have demonstrated that Retatrutide can induce significant and sustained weight loss while also improving key markers such as blood glucose, insulin resistance, and lipid levels. Unlike traditional single-pathway therapies, its multi-receptor activity allows for greater efficacy without compromising safety.
What makes Retatrutide particularly promising is its ability to not only reduce body weight but also mobilize and oxidize stored fat, inhibit new fat accumulation, and potentially improve liver health by reducing markers of fatty liver disease. Importantly, studies so far indicate that it achieves these effects without undue risk of hypoglycemia or severe adverse metabolic disturbances.
Through ongoing clinical evaluation, Retatrutide is emerging as a powerful next-generation therapeutic candidate for obesity, type 2 diabetes, and related metabolic disorders. Designed to deliver deeper, more durable outcomes than GLP-1 therapies alone.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION.
ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
Mix each vial with: Bacteriostatic water. 1-2ml depending on desired dissolution.
Administration: 0.2 mg/ 5-7 days per week